LIST OF ONGOING CLINICAL TRIALS WHICH ARE STILL RECRUITING PATIENTS
as of July 2017

TYPE OF CANCER TITLE HOSPITAL PRINCIPAL INVESTIGATOR
Head and Neck A Randomized, open label, phase III study to evaluate the efficacy and safety of oral afatinib (BIBW 2992) versus intravenous methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who have progressed after platinum-based therapy. SLMC Dr. MG Bello
Head and Neck A Phase II clinical trial of Pembrolizumab (MK-3475) in First Line Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma SLMC Dr. PB Caguioa
A Phase 1 Dose Escalation Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Reximmune-C2 (HSV- Thymidine Kinase-m2 and hGM-CSF) in Refractory Patients with primary Hepatocellular Carcinoma or Tumors Metastatic to the Liver SLMC-QC

SLMC-Global

MMC

TMC

NKTI

Dr. PB Caguioa

Dr. CV Gorospe

Dr. MBE Tamayo

Dr. JP Querol

Dr. NS Juat

Head and Neck A Phase 3 Clinical Trial of Pembrolizumab (MK-3475) in First Line Treatment of Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma. MMC

SLMC

VMMC

TMC

PSH

Dr. MBE Tamayo

Dr. PB Caguioa

Dr. JP Querol

Dr. EEV Regala

Dr. EMB Villegas

Lung A Phase III, Open-Label, Multicenter, Randomized Trial to Establish Safety and Efficacy of an EGFR Cancer Vaccine in Inoperable, Stage IV, Biomarker positive, Wild-type EGFR NSCLC Patients eligible to receive standard treatment and supportive care. MMC Dr. MBE Tamayo
Lung A Multinational, Multicenter, Phase III, Randomized Open-label Trial of Pembrolizumab versus Docetaxel in Previously Treated Subjects with Non-Small Cell Lung Cancer LCP

CSMC

PSH

Dr. GEI Ladrera

Dr. MLA Tiambeng

Dr. JAO Sanchez

Lung A Randomised, Parallel, Double Blinded Study to Compare the Efficacy and Safety of FKB238 to Avastin® In 1st Line Treatment for Patients with Advanced/Recurrent Non-Squamous Non-Small Cell Lung Cancer in Combinationof Paclitaxel and Carboplatin. MMC Dr. MBE Tamayo
Lymphoma A Phase III, randomized, double blind, placebo-controlled study evaluating the efficacy and safety of Copanlisib in combination with Rituximab in patients with relapsed indolent B-cell Non-Hodgkin’s Lymphoma (iNHL) – CHRONOS-3 TMC Dr. BJ Tiangco
Sarcoma AA Phase I/II study evaluating the impact of NBTXR3 nanoparticles activated by pre-operative radiotherapy in Locally Advanced Soft Tissue Sarcoma TMC Dr. BJ Tiangco